Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
Cambrian Biopharma
company
About
Cambrian is a distributed development company building therapeutics to lengthen health span.
- 11 - 50
Details
- Last Funding Type
- Series A
- Industries
- Biopharma,Biotechnology,Life Science
- Founded date
- Jan 1, 2019
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Cambrian Biopharma is building the medicines that will modernize healthcare in the 21st century – therapeutics to lengthen healthspan, the period of life spent in good health.As a Distributed Development Company (or DisCo), Cambrian is advancing multiple scientific breakthroughs, each targeting a biological driver of aging. Our approach is to develop interventions that treat specific diseases first, then deploy them as preventative medicines to improve quality of life/overall quality of life as we age.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
3
$160M
Cambrian Biopharma has raised a total of
$160M
in funding over 2 rounds. Their latest funding was raised on
Oct 26, 2021 from a Series C round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Oct 26, 2021 | Series C | $100M | 2 | — | — | Detail |
| Feb 9, 2021 | Series B | $60M | 1 | — | — | Detail |
| Nov 1, 2019 | Series A | — | 1 | — | — | Detail |
Investments
Number of Investments
Number of Lead Investments
1
0
Cambrian Biopharma has made 1 investments. Their most recent investment was on
Apr 13, 2021, when Arcellx raised 0.
Investors
Number of Lead Investors
Number of Investors
—
3
Cambrian Biopharma is funded by 3 investors.
Korify Capital
and Kliwla Family Office AG
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Korify Capital
|
— | Series C |
Kliwla Family Office AG
|
— | Series C |
NJF Capital
|
— | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
